266 related articles for article (PubMed ID: 11406560)
41. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
Keledjian K; Kyprianou N
J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
[TBL] [Abstract][Full Text] [Related]
42. Inducing apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z by bcl-xL short hairpin RNA.
He CW; Liu F; Zhang YF; Liang T; Zhou KY
Ai Zheng; 2005 Jun; 24(6):646-52. PubMed ID: 15946471
[TBL] [Abstract][Full Text] [Related]
43. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.
Lebedeva IV; Sarkar D; Su ZZ; Kitada S; Dent P; Stein CA; Reed JC; Fisher PB
Oncogene; 2003 Nov; 22(54):8758-73. PubMed ID: 14647471
[TBL] [Abstract][Full Text] [Related]
44. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells.
Sun SY; Yue P; Chen X; Hong WK; Lotan R
Cancer Res; 2002 Apr; 62(8):2430-6. PubMed ID: 11956107
[TBL] [Abstract][Full Text] [Related]
45. Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src.
Sakuma Y; Takeuchi T; Nakamura Y; Yoshihara M; Matsukuma S; Nakayama H; Ohgane N; Yokose T; Kameda Y; Tsuchiya E; Miyagi Y
J Pathol; 2010 Apr; 220(5):574-85. PubMed ID: 20146241
[TBL] [Abstract][Full Text] [Related]
46. Differential expression of antiapoptotic genes in human endometrial carcinoma: bcl-XL succeeds bcl-2 function in neoplastic cells.
Crescenzi E; Criniti V; Pianese M; Tecce MF; Palumbo G
Gynecol Oncol; 2000 Jun; 77(3):419-28. PubMed ID: 10831353
[TBL] [Abstract][Full Text] [Related]
47. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
[TBL] [Abstract][Full Text] [Related]
48. Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy.
Kruyt FA; Schuringa JJ
Biochem Pharmacol; 2010 Aug; 80(4):423-30. PubMed ID: 20394737
[TBL] [Abstract][Full Text] [Related]
49. Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells.
Rosen K; Rak J; Leung T; Dean NM; Kerbel RS; Filmus J
J Cell Biol; 2000 Apr; 149(2):447-56. PubMed ID: 10769035
[TBL] [Abstract][Full Text] [Related]
50. Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells.
Yawata A; Adachi M; Okuda H; Naishiro Y; Takamura T; Hareyama M; Takayama S; Reed JC; Imai K
Oncogene; 1998 May; 16(20):2681-6. PubMed ID: 9632144
[TBL] [Abstract][Full Text] [Related]
51. Anoikis and metastatic potential of cloudman S91 melanoma cells.
Zhu Z; Sanchez-Sweatman O; Huang X; Wiltrout R; Khokha R; Zhao Q; Gorelik E
Cancer Res; 2001 Feb; 61(4):1707-16. PubMed ID: 11245487
[TBL] [Abstract][Full Text] [Related]
52. Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
Brotin E; Meryet-Figuière M; Simonin K; Duval RE; Villedieu M; Leroy-Dudal J; Saison-Behmoaras E; Gauduchon P; Denoyelle C; Poulain L
Int J Cancer; 2010 Feb; 126(4):885-95. PubMed ID: 19634140
[TBL] [Abstract][Full Text] [Related]
53. Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.
Carduner L; Picot CR; Leroy-Dudal J; Blay L; Kellouche S; Carreiras F
Exp Cell Res; 2014 Jan; 320(2):329-42. PubMed ID: 24291221
[TBL] [Abstract][Full Text] [Related]
54. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration.
Caneba CA; Bellance N; Yang L; Pabst L; Nagrath D
Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1036-52. PubMed ID: 22895781
[TBL] [Abstract][Full Text] [Related]
55. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.
Mok SC; Chan WY; Wong KK; Muto MG; Berkowitz RS
Oncogene; 1996 May; 12(9):1895-901. PubMed ID: 8649850
[TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cells.
Rosen K; Coll ML; Li A; Filmus J
J Biol Chem; 2001 Oct; 276(40):37273-9. PubMed ID: 11487584
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state.
Fernández Y; Gu B; Martínez A; Torregrosa A; Sierra A
Int J Cancer; 2002 Oct; 101(4):317-26. PubMed ID: 12209955
[TBL] [Abstract][Full Text] [Related]
58. The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium.
Choi KC; Kang SK; Tai CJ; Auersperg N; Leung PC
J Clin Endocrinol Metab; 2001 May; 86(5):2125-35. PubMed ID: 11344217
[TBL] [Abstract][Full Text] [Related]
59. Merosin (laminin-2/4)-driven survival signaling: complex modulations of Bcl-2 homologs.
Laprise P; Vallée K; Demers MJ; Bouchard V; Poirier EM; Vézina A; Reed JC; Rivard N; Vachon PH
J Cell Biochem; 2003 Aug; 89(6):1115-25. PubMed ID: 12898510
[TBL] [Abstract][Full Text] [Related]
60. CIIA is a novel regulator of detachment-induced cell death.
Kim KJ; Yu JW; Hwang HS; Choi EJ
Cancer Res; 2010 Aug; 70(15):6352-8. PubMed ID: 20670956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
